OM250117C4000
- 0.05
- 0.000.00%
Outset Medical Newsroom
Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Outset Medical Analyst Ratings
RBC Capital Maintains Outset Medical(OM.US) With Hold Rating, Maintains Target Price $3
Outset Medical's Financial Strength and Sales Growth: A Buy Rating From Rick Wise
Outset Medical (OM) Receives a Buy From BTIG
Outset Medical Secures New Financing and Debt Facility
Express News | Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors
Press Release: Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors
Analysts' Opinions Are Mixed on These Healthcare Stocks: Outset Medical (OM), Arvinas Holding Company (ARVN) and Innovent Biologics (OtherIVBXF)
Outset Medical to Present at the 2024 Stifel Healthcare Conference
Outset Medical (OM) Slipped on Earnings Miss and Reduced Guidance
Outset Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Outset Medical Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Sales Guidance.
Outset Medical | 10-Q: Q3 2024 Earnings Report
Stifel Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $6
Outset Medical Inc (OM) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges
Analysts Are Bullish on Top Healthcare Stocks: AnaptysBio (ANAB), Outset Medical (OM)
Outset Medical Inc. (OM) Q3 2024 Earnings Call Transcript Summary
Outset Medical Inc. (OM) Q3 2024 Earnings Call Transcript
TD Cowen Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $3